Comparison of National Medical Products Administration, FDA and ICH guidelines in biowaiver based on biopharmaceutics classification system

WANG Gong-fu; TANG Jia; BAI Yu; XU Zhen-yu

doi:10.3969/j.issn.1003-3734.2022.23.012

Home>Articles>Comparison of National Medical Products Administration, FDA and ICH guidelines in biowaiver based on biopharmaceutics classification system

DOI: 10.3969/j.issn.1003-3734.2022.23.012

Comparison of National Medical Products Administration, FDA and ICH guidelines in biowaiver based on biopharmaceutics classification system

WANG Gong-fu

TANG Jia

BAI Yu

XU Zhen-yu

Machine-generated Keywords：

Publication Date：2022-12-15

Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)

Pages：6( 2355-2360 )

Chinese Journal of New Drugs

ISTICPKU

ISSN：1003-3734

Year, Vol.(Issue)：2022,31(23)